Enrollment change • Trial completion date • Trial termination • Trial primary completion date
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • MYCN (MYCN Proto-Oncogene BHLH Transcription Factor)
|
MYCN amplification
|
nivatrotamab (GD2xCD3)